Scarica l'app Stockscreener
0.8657
0.33%
-0.0029
Dopo l'orario di chiusura:
.87
0.0043
+0.50%
Precedente Chiudi:
$0.8686
Aprire:
$0.8762
Volume 24 ore:
1.52M
Relative Volume:
0.63
Capitalizzazione di mercato:
$140.82M
Reddito:
-
Utile/perdita netta:
$-111.13M
Rapporto P/E:
-0.6558
EPS:
-1.32
Flusso di cassa netto:
$-91.53M
1 W Prestazione:
-0.05%
1M Prestazione:
+32.49%
6M Prestazione:
-28.45%
1 anno Prestazione:
-77.22%
Intervallo 1D:
$0.8562
$0.899
Intervallo di 1 settimana:
$0.7902
$0.95
Portata 52W:
$0.36
$4.06
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Nome
Tenaya Therapeutics Inc
Settore
Industria
Telefono
415-865-2066
Indirizzo
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Confronta TNYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.8657 | 141.29M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-10 | Iniziato | William Blair | Outperform |
| 2023-11-30 | Iniziato | Leerink Partners | Outperform |
| 2022-06-15 | Iniziato | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
Is Tenaya Therapeutics Inc. stock a growth or value playFree Investment Risk Control - jammulinksnews.com
What drives Tenaya Therapeutics Inc. stock pricePowerful profit generation - Autocar Professional
Tenaya Therapeutics Inc. Stock Analysis and ForecastFree Trading Strategy Suggestions - jammulinksnews.com
What analysts say about Tenaya Therapeutics Inc. stockHigh-impact investment strategies - jammulinksnews.com
Is Tenaya Therapeutics Inc. a good long term investmentRapid profit acceleration - jammulinksnews.com
How Tenaya Therapeutics Inc. stock performs during market volatilitySafe High Return Entry Points - Newser
What institutions are buying Tenaya Therapeutics Inc. stock nowFree Access to Community with 300% Return - beatles.ru
Why Tenaya Therapeutics Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
What makes Tenaya Therapeutics Inc. stock price move sharplyFree Best Performing Stock Suggestions - Newser
58,547 Shares in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Bought by Wealth Enhancement Advisory Services LLC - Defense World
Tenaya Therapeutics appoints new interim principal accounting officer - MSN
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) Stock Price Down 0.3% – Here’s Why - Defense World
FDA clears Rocket Pharmaceuticals’ IND for gene therapy candidate - BioWorld MedTech
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $6.25 - Defense World
Millennium Management LLC Sells 174,447 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World
Squarepoint Ops LLC Decreases Stock Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Nuveen Asset Management LLC Buys 69,377 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Deutsche Bank AG Acquires 97,318 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics Appoints New Directors at Annual Meeting - TipRanks
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - Defense World
Price T Rowe Associates Inc. MD Sells 2,892,201 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock - Investing.com Australia
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock - Investing.com
Tenaya Therapeutics Awards Major Stock Options Package: 461K Shares for Strategic New Hires - Stock Titan
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire
Greenlane Renewables Announces First Quarter 2025 Financial Results - The Globe and Mail
Barclays PLC Sells 184,837 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (TNYA) to Showcase Key Research at ASGCT 2025 | TNYA Stock News - GuruFocus
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting - The Manila Times
Tenaya Therapeutics to Present Five Abstracts on Innovative Heart Disease Gene Therapies at ASGCT 2025 Annual Meeting - Nasdaq
Tenaya Therapeutics to Highlight Capsid Engineering, Gene - GlobeNewswire
Hsbc Holdings PLC Purchases New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Equities Analysts Issue Forecasts for TNYA Q2 Earnings - Defense World
Tenaya Therapeutics’ (TNYA) Buy Rating Reiterated at Chardan Capital - Defense World
Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):